IASLC Foundation

Funding Opportunities

The IASLC Foundation awards support for research fellowships across the globe to the next generation of lung cancer physicians and scientists. For inquiries regarding IASLC Foundation’s fellowship opportunities, please contact Foundation Coordinator, Emily Petoskey at Emily.Petoskey@iaslc.org.

  • John’s Legacy Fellowship | Guidelines | Applications Open: October 1, 2018 - December 15, 2018

    The objective of the new IASLCF John’s Legacy Fellowship Award is to encourage that the early detection and screening of lung cancer become a standard of care in annual physicals. The fellowship was conceived by IASLCF board member, Lauren Fisher, in memory of her late husband, John Fisher.

  • IASLC Foundation Fellowship and Young Investigator Awards | Guidelines | Applications Open: October 1, 2018 - December 15, 2018

    Funding for IASLC Foundation Fellowship and Young Investigator Awards provides for the training of research fellows and young investigators who wish to pursue a career in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors.

  • Boehringer Ingelheim IASLC Foundation Chinese Research Fellowship Award | Currently Closed

    Boehringer Ingelheim, in collaboration with the IASLC, have created the Chinese Lung Cancer Fellowship Award to enable a fellow to come to the United States for a one-year research project. The goal of this fellowship is to reward scientific excellence and to encourage innovative and collaborative investigation in the fields of lung cancer prevention, diagnosis and translational research with a potential impact on the management of lung cancer.

  •  Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer Foundation (IASLCF) Joint Fellowship Award | Currently Closed

    The goal of the Lori Monroe Scholarship in Translational Lung Cancer Research is to facilitate the collaboration, information-sharing and interaction between basic researchers and clinical investigators - with the goal of 1) expediting and translating the results of scientific investigation into clinical practice to reduce the burden of lung cancer; or 2) exploring innovative models of lung cancer care delivery; or 3) exploring the etiologies of lung cancer in the never smoker population.

  • Lung Cancer Foundation of America- Bristol-Myers Squibb/IASLCF Young Investigator Research Awards in Translational Immuno-oncology | Currently Closed

    The objective of the LCFA-BMC/IASLCF Young Investigator Research Awards is to support research in translational immune-oncology by early career investigators that aim to improve the care of individuals with lung cancer and to reduce the burden of these diseases.

     

  • Bonnie J Addario Lung Cancer Foundation (ALCF) and the IASLCF Fellowship Award | Currently Closed

    The objective of the ALCF-IASLC funding mechanism is to identify brilliant, young “out of the box” thinkers/researchers who can deliver a meaningful and measurable results for the early detection of lung cancer that has a high probability of near-term benefit to lung cancer patients or individuals at risk, as well as to provide an opportunity for young researchers to learn new cutting-edge technologies and take this expertise back to their home country.

     

  • Prevent Cancer Foundation and the IASLCF Joint Research Grant | Currently Closed

    The goal of this Prevent Cancer Foundation/IASLCF joint grant is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer.

     

  • Free ME from Lung Cancer (FMFLC) and the International Association for the Study of Lung Cancer Foundation (IASLCF) Joint Fellowship Award | Currently Closed

    The FMFLC-IASLC award is designed to fund research that will deliver a meaningful and measurable result for the early detection of lung cancer and that has a high probability of near-term benefit to lung cancer patients or individuals at risk.

     

Thank you to our current partners:

 

Prevent Cancer Foundation